ASO-Mediated DNM2 Knockdown for Centronuclear Myopathies
Engineer
Dynacure
Centronuclear myopathies (CNM) are a group of severe muscle diseases for which no effective therapy is currently available. We have previously shown that reduction of the large GTPase DNM2 in a mouse model of the X-linked form, due to loss of myotubularin phosphatase MTM1, prevents the development of the skeletal muscle pathophysiology. As DNM2 is mutated in autosomal dominant forms, here we tested whether DNM2 reduction can rescue DNM2-related CNM in a knock-in mouse harboring the p. R465W mutation (Dnm2RW/+) and displaying a mild CNM phenotype similar to patients with the same mutation.
This Virtual Poster has been made available to the scientific community by Aurora Scientific, Inc.
Aurora Scientific, Inc.
Aurora Scientific supports the scientific community in its goal of research and discovery by providing precision instrumentation of the highest quality design, construction and functionality for Muscle Physiology, Material Science and Neuroscience applications.
Additional Content From Aurora Scientific, Inc.
Skeletal Muscle Circadian Clocks: Keeping Time for Systemic Health
Dr. Karyn Esser presents the critical role of skeletal muscle circadian clocks in maintaining muscle strength, metabolic health, and systemic adaptations to endurance exercise.
Redox Regulation of Skeletal Muscle: A Journey from Liverpool to the International Space Station
Dr. Anne McArdle and Dr. Malcolm Jackson explore groundbreaking research from the Muscle Laboratories at the University of Liverpool. They examine how redox regulation influences the adaptive responses of skeletal muscle during physical activity and how these processes evolve with age.
Effects of Ovarian Failure on Muscle Form and Function
In this presentation, Parastoo Mashouri, PhD Candidate will explore her pioneering research on the effects of gradual ovarian failure on skeletal muscle function.